Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Regulus Therapeutics

Regulus Therapeutics reported $17K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
AstraZeneca AZN:LN USD 387M 0
Celldex Therapeutics CLDX:US USD 47K 0
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Immunic Inc. VTL:US USD 4K 0
Incyte Corp INCY:US USD 223K 0
Intercept Pharmaceuticals ICPT:US USD 42K 0
Ionis Pharmaceuticals IONS:US USD 143K 1000
Regulus Therapeutics RGLS:US USD 17K 0
Sangamo BioSciences SGMO:US USD 1.72M 50K
Spectrum Pharmaceuticals SPPI:US USD 205K 2K
Takeda 4502:JP JPY 1.68T 11M